CR6395A - Quimioterapia de combinacion - Google Patents

Quimioterapia de combinacion

Info

Publication number
CR6395A
CR6395A CR6395A CR6395A CR6395A CR 6395 A CR6395 A CR 6395A CR 6395 A CR6395 A CR 6395A CR 6395 A CR6395 A CR 6395A CR 6395 A CR6395 A CR 6395A
Authority
CR
Costa Rica
Prior art keywords
combination chemotherapy
combination
fenil
paclitaxel
compound
Prior art date
Application number
CR6395A
Other languages
English (en)
Inventor
Carelton Gowan Richard
Leopold Sebold Judith
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of CR6395A publication Critical patent/CR6395A/es

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

INHIBIDORES MITOTICO TALES COMO EL PACLITAXEL TIENEN ACTIVIDAD ANTITUMORAL MEJORADA UANDO SE USAN EN COMBINACION CON UN INHIBIDOR DE MEK SELECTIVO ESPECIALMENTE UN COMPUESTO FENIL AMINA DE LA FORMULA (I) Y (II).
CR6395A 1998-12-22 2001-06-19 Quimioterapia de combinacion CR6395A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11329198P 1998-12-22 1998-12-22

Publications (1)

Publication Number Publication Date
CR6395A true CR6395A (es) 2004-03-09

Family

ID=27733552

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6395A CR6395A (es) 1998-12-22 2001-06-19 Quimioterapia de combinacion

Country Status (2)

Country Link
CR (1) CR6395A (es)
ZA (1) ZA200104277B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5651125B2 (ja) 2008-12-10 2015-01-07 デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド Mek阻害剤に対する耐性を付与するmek突然変異
RU2571930C2 (ru) 2010-02-25 2015-12-27 Дана-Фарбер Кэнсер Инститьют, Инк. Мутации braf, обеспечивающие резистентность к ингибиторам braf
US20150141470A1 (en) 2012-05-08 2015-05-21 The Broad Institute, Inc. Diagnostic and treatment methods in patients having or at risk of developing resistance to cancer therapy

Also Published As

Publication number Publication date
ZA200104277B (en) 2002-08-26

Similar Documents

Publication Publication Date Title
AP2001002175A0 (en) Combination chemotherapy.
ECSP941111A (es) Nuevas sulfonilaminopirimidinas,
ZA200108204B (en) Cyclo-alkyl substituted benzimidazoles and their use as PARP inhibitors.
AU2003255845A8 (en) Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
NO20052887D0 (no) Pyridazinonderivater som GSK-3Beta inhibitorer.
PT892780E (pt) Analogos de m-amidino fenilo como inibidores do factor xa
PT1202724E (pt) Metodo para tratamento da dor cronica utilizando inibidores mek
DE60336394D1 (de) Transdermale analgetische systeme mit reduziertem missbrauchspotential
AR015379A1 (es) Ascorbil-fosforil-colesterol
PT1165069E (pt) Composicao sinergistica antitumoral
NO20031006L (no) Imidazolo-5-yl-2-anilino-pyrimidiner som midler for inhibering av celleproliferasjon
BR9906070A (pt) Benzamidas substituìdas
DK1718322T3 (da) Synergistiske sammensætninger med FK-228
MY123585A (en) Tri-aryl-substituted-ethane pde4 inhibitors.
GT199900173A (es) Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia disminuida.
ES2151249T3 (es) Hidroxiamidino-derivados utiles como inhibidores de oxido nitrico sintasa.
FI20002044A0 (fi) Comt-entsyymiä estäviä naftaleenijohdannaisia
DE50310323D1 (de) Wässrige polyurethanzubereitungen
ATE476419T1 (de) Isochinolinon-kaliumkanalinhibitoren
IL178727A (en) Tetrahydropyridothiophene derivatives and pharmaceutical compositions containing the same
ATE397861T1 (de) Synergistische zusammensetzungen
CR6395A (es) Quimioterapia de combinacion
ITMI20031714A1 (it) Formazioni ad azione antitumorale.
NO20014753D0 (no) C(10)-karbonatsubstituerte taksaner som antitumormidler
PL376130A1 (en) Controlled releases system containing temozolomide

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)